Literature DB >> 33408347

Sexual function and rehabilitation after radiation therapy for prostate cancer: a review.

David-Dan Nguyen1, Alejandro Berlin2, Andrew G Matthew3, Nathan Perlis3, Dean S Elterman4.   

Abstract

The treatment of prostate cancer is partly guided by patient preferences. Radical prostatectomy and radiation therapy are the standard radical therapies for localized disease and render comparable oncologic outcomes. Considering that survival is high regardless of the chosen treatment, factors such as treatment-related toxicities affecting the patients' quality of life play an important role in their decision. Notably, post-treatment sexual dysfunction, which includes decreased libido, erectile dysfunction, and ejaculatory dysfunction has been shown to be an important and prevalent concern of prostate cancer survivors. In this literature review, we sought to characterize the sexual complications associated with radiation therapy and map the available sexual rehabilitation options for prostate cancer survivors experiencing sexual dysfunction as a result of radiation therapy. We identified medical, non-biomedical, counseling, and lifestyle modification options for prostate cancer survivors seeking sexual rehabilitation. Future research in this area should address the standardization of sexual side-effect reporting and investigate sexual outcomes and rehabilitation in more diverse groups and of transgender and nonheterosexual prostate cancer survivors.

Entities:  

Mesh:

Year:  2021        PMID: 33408347     DOI: 10.1038/s41443-020-00389-1

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  55 in total

1.  Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years.

Authors:  Daniel A Barocas; JoAnn Alvarez; Matthew J Resnick; Tatsuki Koyama; Karen E Hoffman; Mark D Tyson; Ralph Conwill; Dan McCollum; Matthew R Cooperberg; Michael Goodman; Sheldon Greenfield; Ann S Hamilton; Mia Hashibe; Sherrie H Kaplan; Lisa E Paddock; Antoinette M Stroup; Xiao-Cheng Wu; David F Penson
Journal:  JAMA       Date:  2017-03-21       Impact factor: 56.272

2.  Dose of radiation received by the bulb of the penis correlates with risk of impotence after three-dimensional conformal radiotherapy for prostate cancer.

Authors:  B M Fisch; B Pickett; V Weinberg; M Roach
Journal:  Urology       Date:  2001-05       Impact factor: 2.649

3.  Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.

Authors:  J L Donovan; F C Hamdy; J A Lane; D E Neal; M Mason; C Metcalfe; E Walsh; J M Blazeby; T J Peters; P Holding; S Bonnington; T Lennon; L Bradshaw; D Cooper; P Herbert; J Howson; A Jones; N Lyons; E Salter; P Thompson; S Tidball; J Blaikie; C Gray; P Bollina; J Catto; A Doble; A Doherty; D Gillatt; R Kockelbergh; H Kynaston; A Paul; P Powell; S Prescott; D J Rosario; E Rowe; M Davis; E L Turner; R M Martin
Journal:  N Engl J Med       Date:  2016-09-14       Impact factor: 91.245

4.  10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer.

Authors:  Freddie C Hamdy; Jenny L Donovan; J Athene Lane; Malcolm Mason; Chris Metcalfe; Peter Holding; Michael Davis; Tim J Peters; Emma L Turner; Richard M Martin; Jon Oxley; Mary Robinson; John Staffurth; Eleanor Walsh; Prasad Bollina; James Catto; Andrew Doble; Alan Doherty; David Gillatt; Roger Kockelbergh; Howard Kynaston; Alan Paul; Philip Powell; Stephen Prescott; Derek J Rosario; Edward Rowe; David E Neal
Journal:  N Engl J Med       Date:  2016-09-14       Impact factor: 91.245

Review 5.  Adverse effects of androgen deprivation therapy and strategies to mitigate them.

Authors:  Paul L Nguyen; Shabbir M H Alibhai; Shehzad Basaria; Anthony V D'Amico; Philip W Kantoff; Nancy L Keating; David F Penson; Derek J Rosario; Bertrand Tombal; Matthew R Smith
Journal:  Eur Urol       Date:  2014-08-02       Impact factor: 20.096

6.  Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer.

Authors:  John L Gore; Lorna Kwan; Steve P Lee; Robert E Reiter; Mark S Litwin
Journal:  J Natl Cancer Inst       Date:  2009-06-09       Impact factor: 13.506

7.  Long-term functional outcomes after treatment for localized prostate cancer.

Authors:  Matthew J Resnick; Tatsuki Koyama; Kang-Hsien Fan; Peter C Albertsen; Michael Goodman; Ann S Hamilton; Richard M Hoffman; Arnold L Potosky; Janet L Stanford; Antoinette M Stroup; R Lawrence Van Horn; David F Penson
Journal:  N Engl J Med       Date:  2013-01-31       Impact factor: 91.245

Review 8.  Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis.

Authors:  Christopher J D Wallis; Refik Saskin; Richard Choo; Sender Herschorn; Ronald T Kodama; Raj Satkunasivam; Prakesh S Shah; Cyril Danjoux; Robert K Nam
Journal:  Eur Urol       Date:  2015-12-15       Impact factor: 20.096

9.  Sexual rehabilitation after treatment for prostate cancer.

Authors:  L R Schover
Journal:  Cancer       Date:  1993-02-01       Impact factor: 6.860

10.  Waning sexual function--the most important disease-specific distress for patients with prostate cancer.

Authors:  A R Helgason; J Adolfsson; P Dickman; M Fredrikson; S Arver; G Steineck
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

View more
  2 in total

Review 1.  Pelvic Radiation Disease.

Authors:  Tarik Sammour; Arman A Kahokehr
Journal:  Clin Colon Rectal Surg       Date:  2022-02-12

Review 2.  Sexual health-related care needs among young adult cancer patients and survivors: a systematic literature review.

Authors:  Vicky Lehmann; Ellen T M Laan; Brenda L den Oudsten
Journal:  J Cancer Surviv       Date:  2021-10-20       Impact factor: 4.062

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.